RMSL RemSleep Holdings

REMSleep Holdings, Inc. Issues Statement Clarifying Unauthorized Twitter Post and Account

REMSleep Holdings, Inc. Issues Statement Clarifying Unauthorized Twitter Post and Account

Tampa FL, Jan. 27, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- REMSleep Holdings, Inc. (OTC: RMSL) (the “Company”) has become aware of an unauthorized Twitter post incorrectly stating that the Company does not have any notes outstanding.  Although the three 12% $35,000 convertible promissory notes issued by the Company on May 3, 2019 have been fully converted into common stock and are no longer outstanding, the Company’s three 12% $55,000 convertible promissory notes issued by the Company on October 4, 2019 remain outstanding and due on July 4, 2020, if not paid or converted into common stock prior the maturity date in accordance with their terms.  

The Company also wants to notify stockholders that it does not currently have any social media accounts but is in the process of establishing an official Twitter page. The Company will issue a press release with the name of its Twitter page once it has been established.   

The Company encourages those interested in the Company to rely solely on information included in Company’s filings with the U.S. Securities and Exchange Commission through the SEC EDGAR Database at  and filings with and press releases posted by the Company on the OTC Markets Group website. 

The Company responds from time to time to inquiries from shareholders, potential investors, investment analysts, and journalists on a regular basis. However, to the Company's knowledge, neither the Company, nor any of its officers and directors have directly been involved with the creation or distribution of promotional materials and newsletters that make exaggerated or misleading claims related to the Company and its securities.

Forward-looking Statements. This press release may contain forward-looking statements regarding Company. All statements, other than statements of historical fact included herein, are "forward-looking statements" including statements regarding the Company’s future prospects and risks in investing in Company’s common stock. These statements are based upon the Company's current expectations and speak only as of the date hereof. Financial performance in one period does not necessarily mean continued or better performance in the future. The Company's actual results in any endeavor may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, which factors or uncertainties may be beyond our ability to foresee or control. Other risk factors include the status of the Company's common stock as a "penny stock" and those risk factors stated in reports filed with the U.S. Securities and Exchange Commission or “SEC” on its EDGAR website (URL: .

REMSleep Holdings Inc.

912-590-6048

EN
27/01/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on RemSleep Holdings

 PRESS RELEASE

REMSleep Patent Application Has Been Allowed by the United States Pate...

REMSleep Patent Application Has Been Allowed by the United States Patent and Trademark Office CLEARWATER, FL, Sept. 03, 2024 (GLOBE NEWSWIRE) -- REMSleep Holdings, Inc. (OTCQB: RMSL) announces that another utility patent for its Nasal Ventilation System has been allowed by the United States Patent and Trademark Office.  REMSleep will file the necessary paperwork to pay for issuance and, thereafter, REMSleep should be awarded a patent in approximately 8 weeks.  REMSleep will maintain a continuation application for adding any improvements and/or changes to the patent lineage. REMSleep is...

 PRESS RELEASE

REMSleep Holdings Inc. Issues Shareholder Letter

REMSleep Holdings Inc. Issues Shareholder Letter Company Unveils Internal Corporate Goal of Capturing 10% of the CPAP Mask Market Within 24 Months CLEARWATER, Fla., Aug. 06, 2024 (GLOBE NEWSWIRE) -- REMSleep Holdings, Inc. (OTCQB: RMSL), a leader in innovative sleep apnea products, published the following letter to shareholders. Dear REMSleep Shareholders and Interested Investors: Our company’s primary focus is two-fold. First, we are dedicated to providing high-quality products and experiences for CPAP therapy to support our customers and their families. Second, we are intensely ...

 PRESS RELEASE

REMSleep Holdings, Inc. Announces Distributor Request for DELTAWAVE Na...

REMSleep Holdings, Inc. Announces Distributor Request for DELTAWAVE Nasal Pillows System Samples CLEARWATER, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- REMSleep Holdings, Inc. (OTCQB: RMSL), a leader in innovative sleep apnea products, is thrilled to announce that a significant distributor in the CPAP industry has requested samples of its new nasal interface, the DELTAWAVE Nasal Pillows System. This request marks a pivotal step in REMSleep's mission to revolutionize sleep apnea treatment with cutting-edge technology and superior comfort. REMSleep is currently in the process of preparing the...

 PRESS RELEASE

REMSleep Holdings Inc. Announces Strategic Marketing Plan for DELTAWAV...

REMSleep Holdings Inc. Announces Strategic Marketing Plan for DELTAWAVE Nasal Pillows System CLEARWATER, Fla., July 17, 2024 (GLOBE NEWSWIRE) -- REMSleep Holdings Inc. (OTCQB: RMSL), a pioneer in sleep apnea treatment solutions, is thrilled to announce a comprehensive marketing strategy for its revolutionary DELTAWAVE Nasal Pillows System. This strategic plan aims to significantly expand the market presence of DELTAWAVE by identifying and partnering with key distributors nationwide The DELTAWAVE Nasal Pillows System, designed with cutting-edge technology, offers an innovative solution fo...

 PRESS RELEASE

REMSleep Holdings Inc. Receives 510(K) Clearance on Product

REMSleep Holdings Inc. Receives 510(K) Clearance on Product CLEARWATER, Fla., July 09, 2024 (GLOBE NEWSWIRE) -- REMSleep Holdings, Inc. (OTCQB: RMSL) announces the company has been awarded 510(K) Clearance for the new Deltawave CPAP Pillows Interface mask. The company would like to share the following correspondence with its shareholders: Re: K233415Trade/Device Name: DELTAWAVE Nasal Pillows SystemRegulation Number: 21 CFR 868.5905Regulation Name: Noncontinuous Ventilator (IPPB)Regulatory Class: Class IIProduct Code: BZDDated: October 4, 2023Received: October 10, 2023 Dear Judy Strzepek...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch